[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.94.5. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
January 22/29, 2003

Financial Consequences of Drug Benefit PlansFinancial Consequences of Drug Benefit Plans

Author Affiliations
 

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;289(4):423-424. doi:10.1001/jama.289.4.423-a

To the Editor: The results of Dr Joyce and colleagues1 do not seem surprising. Innovations in benefit packages, such as increased co-payments, are intended to have a direct fiscal effect by reducing insurers' costs. Furthermore, it is generally hoped that the increased out-of-pocket expenses would reduce the moral hazard problem created by insurance.

First Page Preview View Large
First page PDF preview
First page PDF preview
×